Evidence map›Paper›PMID 33864052›Full record

ArticleNature medicine2021

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.

Giulia Giordano, Marta Colaneri, Alessandro Di Filippo, Franco Blanchini, Paolo Bolzern, Giuseppe De Nicolao, Paolo Sacchi, Patrizio Colaneri, Raffaele Bruno

Abstract read
In one paragraph

Article in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giulia GiordanoDepartment of Industrial Engineering, University of Trento, Trento, Italy. giulia.giordano@unitn.it.ORCID http://orcid.org/0000-0002-8600-1738
Marta ColaneriDivision of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Alessandro Di FilippoDivision of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Franco BlanchiniDipartimento di Scienze Matematiche, Informatiche e Fisiche, University of Udine, Udine, Italy.
Paolo BolzernDipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Giuseppe De NicolaoDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Paolo SacchiDivision of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Patrizio Colaneri *Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Raffaele Bruno *Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101016233, H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
6 · The paper itself

Abstract

Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19)

Indexed as

COVID-19COVID-19 VaccinesHumansItalyPandemicsSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID33864052
PMCPMC8205853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.